<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Tarbiat Modares University</PublisherName>
				<JournalTitle>Pathobiology Research</JournalTitle>
				<Issn>2538-3000</Issn>
				<Volume>22</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>07</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Expression of the Recombinant Hsp20-Nef Protein for Evaluation of its Immunogenicity against HIV-1 Nef using Indirect ELISA</ArticleTitle>
<VernacularTitle>بیان پروتئین نوترکیب Hsp20-Nef به‌منظور ارزیابی ایمنوژنیسیتی آن در مقابل HIV-1 Nef توسط الایزای غیرمستقیم</VernacularTitle>
			<FirstPage>135</FirstPage>
			<LastPage>140</LastPage>
			<ELocationID EIdType="pii">19353</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>B.</FirstName>
					<LastName>Rostami</LastName>
<Affiliation>Biology Department, Sciences &amp; Research Branch, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sh.</FirstName>
					<LastName>Irani</LastName>
<Affiliation>Biology Department, Sciences &amp; Research Branch, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>A.</FirstName>
					<LastName>Bolhassani</LastName>
<Affiliation>Hepatitis &amp; AIDS Department, Pasteur Institute of Iran, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>R.</FirstName>
					<LastName>Ahangari Cohan</LastName>
<Affiliation>Pilot Nano-Biotechnology Department, Pasteur Institute of Iran, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
		    <Abstract>Aims: Nef protein has been considered as an attractive target for the development of therapeutic HIV-1 vaccine. Furthermore, strong immunological properties of heat shock proteins (HSPs) led to their use as for subunit vaccine candidates. In the current study, the generation of Hsp20-Nef fusion protein was performed in E.  , and in BALB/c mice.
Materials and Methods: At first, of Hsp20-Nef recombinant protein E. BL21 and Rosetta strains by SDS-PAGE and western blotting using anti-Nef monoclonal antibody. Then, the recombinant protein was purified by a reverse staining method. Finally, its potency was evaluated to elicit antibody response against HIV-1 Nef antigen using indirect ELISA in mice.
Findings: Our data showed a clear band of ~1230bp related to Hsp20-Nef fusion on agarose gel indicating the correct gene cloning in pET28a vector. The expression of Hsp20-Nef protein was confirmed as a clear band of ~47 SDS-PAGE and western blotting. In the immunological assay, the Hsp20-Nef protein and also the Nef protein emulsified with Freund’s adjuvant significantly enhanced the level of total compared to other groups. Moreover, of Hsp20-Nef was higher than Freund’s adjuvant/Nef in protein regimens (p&lt;0.05).
Conclusion: The Hsp20-Nef fusion protein was effectively expressed in E.  and significantly induced antibody response against HIV-1 Nef antigen.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">HIV</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nef</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hsp20</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bacterial expression system</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Immunogenicity</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://mjms.modares.ac.ir/article_19353_35afcb39dad0fd02235dedfab3beb4ab.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
